This section will contain updates from the pain industry.

Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription

Eli Lilly and Company announced today that REYVOW™ (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment of migraine with or without aura in adults, is now available for prescription and w...
Continue reading
Topics:

Novel Gene Therapies for Precision Pain Management Published by Pharmafile

 Article emphasizes the need of alternative approaches to manage pain and specifically focuses on the genetics of pain and gene therapy solutions. Full story.  
Topics:

Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with a History of Inadequate Response

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that AXS-07, Axsome's novel, oral, multi-mech...
Continue reading
Topics:

Los Angeles Startup Uses AI to Reduce Unnecessary Spine Surgeries

A Los Angeles-based startup recently struck a licensing deal with the University of California- Los Angeles to create a tool that can analyze spine images to help decide whether patients should be a candidate for surgery.

Continue reading
Topics:

AAPM 2020 Resource Center Opportunities

Exhibits, scientific posters, attendee receptions, Meet the Faculty events, and much more are planned for the AAPM 2020 Resource Center. Attendees will have opportunities to connect with colleagues and learn about the la...
Continue reading
Topics:

New Novartis Medicine Adakveo® (crizanlizumab) Approved by FDA to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease

  Read the full story.
Topics:
FDA

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

 BioElectronics Corporation, the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management , titled " A Prospective Six-Month S...
Continue reading

FDA Approves New Treatment for Patients with Migraine

The U.S. Food and Drug Administration approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow i...
Continue reading
Topics:

AI-Powered Motion Tracking Technology for Back Pain and COPD: Interview with Rutger Flohil, US CEO of Kaia Health

Kaia Health, a health technology company based in New York City, has developed a smartphone app that can guide users through exercises to help with back pain and COPD. The technology uses AI powered motion tracking techn...
Continue reading

ATI Physical Therapy Launches ATIFirst Program and Outcomes and Best Practices Initiative

Physical therapy first offers faster diagnosis and treatment, lower health care costs and no drugs needed. Industry is beginning to shift its view of the value of using physical therapy first for chronic musculoskeletal pain conditions. 

Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More